Yifan Pharmaceutical Co Ltd’s stock price surges as the company rides the wave of synthetic biology and innovation in the pharmaceutical sector, driven by strategic collaborations and a focus on global expansion.

Yifan Pharmaceutical Co Ltd’s stock has surged 9.17% as of May 29, 2025, driven by anticipation of the ASCO conference and the company’s strategic developments in innovation and international expansion.